Topchoice Medical Co., Inc. (SHA:600763)

Topchoice Medical Co. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	14,506	17,985	19,860	24,513	49,055	63,807
Market Cap Growth	-31.52%	-9.44%	-18.98%	-50.03%	-23.12%	-28.03%
Enterprise Value	15,690	19,085	21,039	25,551	49,953	63,811
Last Close Price	32.43	40.21	43.92	53.55	107.17	139.40

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	23.53	35.83	39.64	48.98	89.47	90.79
Forward PE	25.67	37.43	46.14	29.21	76.15	75.61
PS Ratio	4.87	6.17	6.91	8.61	18.04	22.95
PB Ratio	3.20	3.94	4.56	5.93	13.56	20.29
P/TBV Ratio	3.73	4.51	5.13	6.61	15.10	22.65
P/FCF Ratio	23.39	31.86	46.09	73.81	197.39	111.53
P/OCF Ratio	17.31	22.19	26.03	29.15	73.21	67.92
PEG Ratio	2.86	4.05	4.80	1.60	3.63	1.08

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	5.27	6.55	7.32	8.98	18.37	22.95
EV/EBITDA Ratio	16.95	24.56	26.99	32.78	61.17	63.76
EV/EBIT Ratio	21.48	27.51	30.45	36.80	67.97	68.66
EV/FCF Ratio	25.30	33.81	48.83	76.93	201.01	111.54

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.26	0.24	0.33	0.35	0.32	0.41
Debt / EBITDA Ratio	1.26	1.26	1.62	1.65	1.27	1.20
Debt / FCF Ratio	1.87	1.97	3.35	4.39	4.64	2.27
Net Debt / Equity Ratio	0.18	0.09	0.19	0.21	0.14	0.14
Net Debt / EBITDA Ratio	0.98	0.53	1.06	1.11	0.64	0.46
Net Debt / FCF Ratio	1.28	0.73	1.91	2.60	2.11	0.80
Asset Turnover	0.49	0.48	0.47	0.51	0.54	0.69
Inventory Turnover	52.44	71.86	64.51	73.37	74.42	78.94
Quick Ratio	0.98	1.38	1.43	1.15	1.67	1.56
Current Ratio	1.12	1.49	1.55	1.40	2.33	1.63
Return on Equity (ROE)	15.66%	13.18%	13.46%	14.92%	18.21%	28.62%
Return on Assets (ROA)	7.51%	7.07%	7.03%	7.74%	9.09%	14.49%
Return on Invested Capital (ROIC)	11.59%	11.39%	11.19%	12.40%	15.84%	27.26%
Return on Capital Employed (ROCE)	13.90%	13.00%	12.30%	12.90%	15.70%	21.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	4.24%	2.79%	2.52%	2.04%	1.12%	1.10%
FCF Yield	4.27%	3.14%	2.17%	1.35%	0.51%	0.90%
Dividend Yield	1.29%	-	1.03%	0.58%	-	-
Payout Ratio	-	41.62%	29.92%	2.25%	1.22%	1.83%
Buyback Yield / Dilution	0.37%	0.01%	-0.11%	0.50%	0.09%	-0.32%
Total Shareholder Return	1.66%	0.01%	0.91%	1.08%	0.09%	-0.32%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error